Cargando…
Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression
Cyclophosphaty -45mide (Cyc) chemotherapy in young female cancer patients is associated with an increased risk of premature ovarian insufficiency (POI). This study was designed to investigate the protective role of melatonin (Mel) as an adjuvant against Cyc-induced POI. Female mice received a single...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381702/ https://www.ncbi.nlm.nih.gov/pubmed/35992124 http://dx.doi.org/10.3389/fendo.2022.895095 |
_version_ | 1784769132385796096 |
---|---|
author | Feng, Juan Ma, Wen-Wen Li, Hui-Xia Pei, Xiu-Ying Deng, Shou-Long Jia, Hua Ma, Wen-Zhi |
author_facet | Feng, Juan Ma, Wen-Wen Li, Hui-Xia Pei, Xiu-Ying Deng, Shou-Long Jia, Hua Ma, Wen-Zhi |
author_sort | Feng, Juan |
collection | PubMed |
description | Cyclophosphaty -45mide (Cyc) chemotherapy in young female cancer patients is associated with an increased risk of premature ovarian insufficiency (POI). This study was designed to investigate the protective role of melatonin (Mel) as an adjuvant against Cyc-induced POI. Female mice received a single intraperitoneal (i.p.) dose of Cyc (75 mg/kg). Mel protection was achieved in mice after i.p. injection of melatonin (50 mg/kg) every 24 h for four consecutive days prior to chemotherapy initiation and for 14 additional days. Ovarian reserve testing, hormonal assays for follicle-stimulating hormone, luteinizing hormone, and anti-Müllerian hormone (AMH), assessment of the oxidative stress status, and measurement of the relative expression of genes in PTEN/AKT/FOXO3a and mitochondrial apoptosis pathways were performed. The results showed that treatment with 50 mg/kg Mel significantly prevented Cyc-induced over-activation of primordial follicles by maintaining the plasma level of AMH and subsequently preventing litter size reduction in mice treated with Cyc chemotherapy. Importantly, Mel treatment significantly prevented ovarian granulosa cell loss by inhibiting the mitochondrial apoptotic pathway. Identifying the protective actions of Mel against Cyc-induced primordial follicle loss has important implications for fertility maintenance in young cancer patients undergoing chemotherapy. |
format | Online Article Text |
id | pubmed-9381702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93817022022-08-18 Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression Feng, Juan Ma, Wen-Wen Li, Hui-Xia Pei, Xiu-Ying Deng, Shou-Long Jia, Hua Ma, Wen-Zhi Front Endocrinol (Lausanne) Endocrinology Cyclophosphaty -45mide (Cyc) chemotherapy in young female cancer patients is associated with an increased risk of premature ovarian insufficiency (POI). This study was designed to investigate the protective role of melatonin (Mel) as an adjuvant against Cyc-induced POI. Female mice received a single intraperitoneal (i.p.) dose of Cyc (75 mg/kg). Mel protection was achieved in mice after i.p. injection of melatonin (50 mg/kg) every 24 h for four consecutive days prior to chemotherapy initiation and for 14 additional days. Ovarian reserve testing, hormonal assays for follicle-stimulating hormone, luteinizing hormone, and anti-Müllerian hormone (AMH), assessment of the oxidative stress status, and measurement of the relative expression of genes in PTEN/AKT/FOXO3a and mitochondrial apoptosis pathways were performed. The results showed that treatment with 50 mg/kg Mel significantly prevented Cyc-induced over-activation of primordial follicles by maintaining the plasma level of AMH and subsequently preventing litter size reduction in mice treated with Cyc chemotherapy. Importantly, Mel treatment significantly prevented ovarian granulosa cell loss by inhibiting the mitochondrial apoptotic pathway. Identifying the protective actions of Mel against Cyc-induced primordial follicle loss has important implications for fertility maintenance in young cancer patients undergoing chemotherapy. Frontiers Media S.A. 2022-08-03 /pmc/articles/PMC9381702/ /pubmed/35992124 http://dx.doi.org/10.3389/fendo.2022.895095 Text en Copyright © 2022 Feng, Ma, Li, Pei, Deng, Jia and Ma https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Feng, Juan Ma, Wen-Wen Li, Hui-Xia Pei, Xiu-Ying Deng, Shou-Long Jia, Hua Ma, Wen-Zhi Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression |
title | Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression |
title_full | Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression |
title_fullStr | Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression |
title_full_unstemmed | Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression |
title_short | Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression |
title_sort | melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining amh expression |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381702/ https://www.ncbi.nlm.nih.gov/pubmed/35992124 http://dx.doi.org/10.3389/fendo.2022.895095 |
work_keys_str_mv | AT fengjuan melatoninpreventscyclophosphamideinducedprimordialfolliclelossbyinhibitingovariangranulosacellapoptosisandmaintainingamhexpression AT mawenwen melatoninpreventscyclophosphamideinducedprimordialfolliclelossbyinhibitingovariangranulosacellapoptosisandmaintainingamhexpression AT lihuixia melatoninpreventscyclophosphamideinducedprimordialfolliclelossbyinhibitingovariangranulosacellapoptosisandmaintainingamhexpression AT peixiuying melatoninpreventscyclophosphamideinducedprimordialfolliclelossbyinhibitingovariangranulosacellapoptosisandmaintainingamhexpression AT dengshoulong melatoninpreventscyclophosphamideinducedprimordialfolliclelossbyinhibitingovariangranulosacellapoptosisandmaintainingamhexpression AT jiahua melatoninpreventscyclophosphamideinducedprimordialfolliclelossbyinhibitingovariangranulosacellapoptosisandmaintainingamhexpression AT mawenzhi melatoninpreventscyclophosphamideinducedprimordialfolliclelossbyinhibitingovariangranulosacellapoptosisandmaintainingamhexpression |